|Bid||0.00 x 800|
|Ask||0.00 x 1300|
|Day's range||157.59 - 159.67|
|52-week range||148.51 - 179.92|
|Beta (5Y monthly)||0.70|
|PE ratio (TTM)||23.82|
|Earnings date||25 Jan 2022|
|Forward dividend & yield||4.24 (2.70%)|
|Ex-dividend date||22 Nov 2021|
|1y target est||187.76|
Some Americans could prefer Moderna's booster because of perceptions that it offers higher efficacy.
Robinhood Markets was one of the pioneers of the commission-free investing model that is now so common among online brokers. At the same time, Robinhood has its share of detractors. Johnson & Johnson (NYSE: JNJ) is one of the largest healthcare companies in the world by market cap, but this juggernaut is about to get smaller.
Bristol Myers Squibb (NYSE: BMY) and Johnson & Johnson (NYSE: JNJ) compete against each other in the marketplace every day. In this Motley Fool Live video recorded on Nov. 16, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss the prospects for this experimental drug. Keith Speights: Bristol Myers Squibb and Johnson & Johnson compete head-to-head in the blood thinner market.